Streetbeat News

Earnings

BLDR

Builders FirstSource reported its Q4 2023 adjusted earnings per share (EPS) at $3.55, surpassing the estimated $2.54. Sales reached $4.15 billion, also beating the forecast of $4.03 billion.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:06 pm

NEM

Newmont (NYSE:NEM) reported Q4 2023 adjusted EPS of $0.50, surpassing the $0.46 estimate, with sales of $4B exceeding the $3.45B forecast. This represents a 25% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:06 pm

POOL

Pool Corporation (NASDAQ:POOL) reported Q4 earnings of $1.32 per share, surpassing the consensus estimate of $1.25 by 5.6%. However, their quarterly sales of $1.00 billion fell short of the $1.02 billion estimate, marking an 8.49% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:06 pm

RYTM

Rhythm Pharmaceuticals (NASDAQ:RYTM) reported Q4 earnings with a loss of $(0.70) per share, missing the $(0.69) estimate, and sales of $24.23M, missing the $25.38M estimate. Despite these misses, the company saw a 6.67% decrease in losses and a 175.70% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:05 pm

HEES

H&E Equipment Services (HEES) reported a Q4 EPS of $1.47, up from $1.41 year-over-year, with sales of $385.81M surpassing the $382.59M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:05 pm

AMBP

Ardagh Metal Packaging (AMBP) reported Q4 2023 adjusted EPS of $0.01, missing the $0.04 estimate by 75%, and a decrease of 80% from last year's $0.05. However, their sales of $1.13B exceeded the $1.11B estimate by 1.91%, marking a 5.20% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:05 pm

KLTR

Kaltura (NASDAQ:KLTR) reported Q4 adjusted EPS of $(0.03), meeting analyst estimates, and sales of $44.48M, exceeding the $41.80M estimate. This represents a 50% improvement in losses per share and a 0.93% increase in sales compared to the same period last year.

Portfolio Pulse from mahesh@benzinga.com

February 22, 2024 | 12:05 pm

KYMR

Kymera Therapeutics, symbolized as KYMR, has announced that it is well-capitalized, boasting a cash reserve of $745 million. This financial position is expected to provide the company with a runway extending into the first half of 2027, indicating a strong liquidity position and the ability to fund its operations and research activities for the next several years without the immediate need for additional capital.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:04 pm

LNTH

Lantheus Holdings (NASDAQ:LNTH) reported Q4 adjusted EPS of $1.75, surpassing the $1.45 estimate, and sales of $354M, exceeding the $342.33M estimate. This represents a 27.74% increase in earnings and a 34.52% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:04 pm

NVCR

NovoCure (NASDAQ:NVCR) reported Q4 earnings with losses of $(0.45) per share, surpassing the $(0.52) estimate, and sales of $133.78M, exceeding the $131.19M estimate. This represents a 25% increase in losses and a 4.17% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 12:04 pm